What is the Impact Factor of Expert Opinion on Pharmacotherapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Expert Opinion on Pharmacotherapy is 3.40, ranking in quartile Q2 of Web of Science (SCIE).

Is Expert Opinion on Pharmacotherapy indexed in Web of Science or Scopus?

Yes, Expert Opinion on Pharmacotherapy is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.765 (Q2) and an H-index of 104.

Who publishes Expert Opinion on Pharmacotherapy and what is the Article Processing Charge (APC)?

Expert Opinion on Pharmacotherapy is published by Taylor and Francis Ltd.. The estimated Article Processing Charge (APC) is approximately $3,127 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Expert Opinion on Pharmacotherapy?

The official ISO-4 abbreviation of Expert Opinion on Pharmacotherapy is "EXPERT OPIN. PHARMACOTHER" with common acronym "eoop". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #7,353Top JournalReview JournalHybrid

Expert Opinion on Pharmacotherapy

Acronym:eoop

•

Abbreviation (ISO):EXPERT OPIN. PHARMACOTHER

•

Identifier (ISSN):1465-6566(Print)/1744-7666(Online)

•

Publisher:Taylor and Francis Ltd.

Official Website Submission Portal Compare

Clarivate IF (2026)

3.4↑ +0.7

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Expert Opinion on Pharmacotherapy

WoS Q2

Annual Impact Factor Metric

Current (2026):3.4

Scopus SJR & RankScopus Q2

0.765

#7,353

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

104

104 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

166articles/year

4.26% Gold OA•29.87% Original Research

Aims & Scope

Expert Opinion on Pharmacotherapy is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.

Topics Covered (Recognized by AI)

Medicine99.9%Biology90.7%Internal medicine88.5%Pathology60.6%Genetics51.7%Psychology49.2%Pharmacology47.3%Chemistry46.7%Psychiatry45.6%Intensive care medicine44.1%Biochemistry41.5%Surgery37.6%Endocrinology36%Immunology27.3%Bioinformatics26.6%Disease21.4%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank143/356

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank224/356

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	143/356	Q2
PHARMACOLOGY & PHARMACY	JCISCIE	224/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.4

Articles / Year152

Total Citations35

2025

IF2.7

Articles / Year168

Total Citations440

2024

IF2.5

Articles / Year224

Total Citations1,528

2023

IF3.2

Articles / Year175

Total Citations1,586

2022

IF4.103

Articles / Year194

Total Citations1,719

Year	Impact Factor	Articles / Year	Total Citations
2026	3.4	152	35
2025	2.7	168	440
2024	2.5	224	1,528
2023	3.2	175	1,586
2022	4.103	194	1,719
2021	3.889	211	2,674
2020	2.878	290	5,477
2019	3.038	203	4,988
2018	3.475	246	5,886
2017	—	208	5,519
2016	—	215	4,803
2015	—	273	7,058

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,353Scopus Q2SCImago Profile

Scopus Coverage:1999-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.765

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

3.14

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,127 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,703

3-Year Documents617

Citable Documents533

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate36.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2

PharmacologyQ2

Pharmacology (medical)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Expert Opinion on Pharmacotherapy (acronym: eoop, abbr: EXPERT OPIN. PHARMACOTHER, ISSN: 1465-6566) is a peer-reviewed international scholarly journal in the field of Medicine, published by Taylor and Francis Ltd. in England since 1999. The periodical holds a Journal Impact Factor (JIF) of 3.40, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.765 (Q2), an H-index of 104.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 166 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,127 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.